Introduction
Benign extra-hepatic cholestasis may lead to cholangitis and increased intra-canaliculi pressure, developing acute and chronic hepatic injuries 1, 2 reduced portal flow, [3] [4] [5] [6] increased serum nitric oxide (NO) [7] [8] [9] and triggering of liver lipid peroxidation. [10] [11] [12] Surgical desobstruction is the elective treatment.
Acute liver injuries results, among others, mainly in abscesses, ductal proliferation and reduced number of hepatocyte 2 while secondary biliary cirrhosis is aroused due to chronic injuries. 13 Portal flow may be reduced up to 50% in 7 days. 6 Quantitative and qualitative alterations of the free radicals (FR) enzymes, constitutive NO isoforms (cNOS) 14, 15 and the presence of inducible isoform (iNOS) following the outcome of inflammatory process 9 promotes increases of NO concentration. The accumulation of hydrophobic bile acids during cholestasis leads to mitochondrial FR generation in the liver, consisting of a major mechanism of injury and fibrosis due to the propagation of the lipid peroxidation chain after spontaneous reaction with oxygen. 11, 16, 17 Histological injuries reduced portal flow, increased plasma NO and liver lipid peroxidation associated with extrahepatic cholestasis are events reported by pertinent literature in a isolated manner.
The proposal of this study is to evaluate the above parameters simultaneously in the same experimental model. New investigations are worthwhile to better understand the relation between the aggravating factors of extra-hepatic cholestasis, especially NO and portal flow.
Methods
Twenty six male Wistar rats, weight range 230 e 370 g, were randomly distributed into 3 groups. Group 1: Biliary Occlusion (BO), n=18, submitted to biliary occlusion after sectioning and ligature of choledoch duct. Doppler echography were performed on days 0, 15 and 20 to evaluate portal flow and obtain liver biopsy, whereby 650 and 900 mg pieces were removed for histology and for dosage of NO and malondialdehyde (MDA). Simultaneously, blood was collected from the inferior cava vein for dosage of NO, direct bilirubin (DB) and alkaline phosphatase (AP). Hepatic tissue histology and morphometry were done with biopsy fragments obtained during sacrifice. Group 2: Simulated biliary obstruction as control of portal flow through Doppler echography, (CED), n=4, submitted to biliary simulated obstruction as control for Doppler echography, performed on days 0, 15 and 20. Group 3: Simulated biliary obstruction as control for histology and biochemical dosages, (CHB), n=4, submitted to simulated biliary obstruction and afterwards to hepatic biopsy for dosage of NO and MDA and blood withdrawal on days 0, 15 and 20.
Surgical procedure: After 12 hours of fasting and water ad libitum, the animals were anesthetized by ethyl ether inhalation. Group BO: xiphopubic median laparotomy, acknowledge and distal ligature of choledochus, biopsy pieces removed from the left lobe of the liver on day 0, from the right lobe on day 15 and again left lobe on day 20 with posterior suture. Collection of 2.5 mL of blood from the inferior cava vein. Careful and meticulous hemostasis and abdominal closure in two planes. Groups CED and CHB were submitted to simulated surgery ( Figure 1 ). Histology: Hematoxylin-eosin stain was employed and hepatic tissue morphometry was performed by the evaluation of the volume fractions calculated from the fraction of points overlaying a specific compartment divided by the total number of points counted, which was calculated for hepatocytes, fibroblasts, fibrosis, biliary ducts, blood vessels and inflammatory cells contained in the hepatic tissue.
Direct (Figure 2 ).
FIGURE 2 -Morphometric evaluation of hepatic tissue.
Data is presented as mean. p<0,001 for group BO (20 days) versus group BO/DB (25 days).
Direct bilirubin:
Analysis within group demonstrated in group BO significant difference between basal value and days 15 (p=0,016) and 20 (p=0,02). Analysis between groups revealed significant difference of DB values on days 15 and 20 in groups BO and control (p=0,0002) and (p=0,0046) ( Figure 3) . Portal flow: In group BO mean portal flow value on day 15 was significantly higher than on day 0, on the contrary, day 20 presented significantly reduced value than day 15. In group CED, greater statistically different values was observed for on day 20 compared to basal ( Figure 5 ). Nitric Oxide: For NO plasma values statistical significance was observed within group BO on days 15 and 20 compared to basal value (p= 0,032 and 0,007, respectively). Similar results were noticed between groups BO and control (p= 0,028 and 0,028 respectively) on days 15 and 20. Hepatic tissue did not reveal significant difference either within or between groups ( Figure 6 ). 
Discussion
Contrary to literature data which reports events related to extra-hepatic cholestasis in a isolated manner, the present experiment proposed a simultaneous study of hepatic histological alterations and DB, AP, portal flow, plasma and hepatic NO, and hepatic MDA by performing biliary obstruction in rats. Results demonstrated acute histological alterations, significant rises in DB and AP in the occluded group, significant reduction of portal vein flow, significant augment of plasma NO and hepatic MDA revealing hepatic lipid peroxidation. Reduced portal flow may be attributed to portal vein compression by intense biliary tree dilation, on account that on day 20 there was a significant reduction of portal flow not correspondent to the concomitant rise of plasma NO. Nevertheless, the significant increase in plasma NO may imply in portal vasodilation and consequent decline in flow. Negative findings related to NO in the hepatic tissue, may call to mind that the method using Griess solution chosen by this study, must be substituted by imunohistochemistry. 18, 19 In a simplified manner and based on pertinent literature, the following sequence of physiopathologic events may be suggested:
Conclusion
Biliary obstruction results in morphologic (histology) and functional (increases in direct bilirubin and alkaline phosphatase) alterations of the liver, concomitant to reduction in portal flow and increase of plasmatic NO and hepatic tissue MDA.
